Biomerieux SA (BIM)

In the past 90 days, Biomerieux SA has recorded one insider trading transaction, with Executive Director Guillaume Bouhours selling 2,550 shares valued at approximately €299,370. This sale contributed to a net insider trading value of -€323,499.22, indicating a lack of buying activity among insiders. The company's stock has seen a 4.0% increase over the last 90 days, with the next earnings report scheduled for September 4, 2025.
Stock chart
Ticker: BIM Exchange: PAR


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-26 2025-03-24 S Sale

GUILLAUME BOUHOURS

Directeur Exécutif

Officer
2,550
117.40
EUR 323,499
2,550 117.40 EUR 299,370
2025-03-11 2025-03-10 S Sale

Pierre BOULUD

Directeur Général

Officer
5,741
117.30
EUR 729,448
5,741 117.30 EUR 673,419
2024-11-19 2024-10-04 B Purchase

Alexandre Merieux

Président du Conseil d'administration

Through COMPAGNIE MERIEUX ALLIANCE, a closely affiliated person Director
58,148
1,393.04
EUR 89,353,847
58,148 1,393.04 EUR 81,002,490
2024-09-10 2024-09-10 S Sale

YASHA MITROTTI VENTURA

Executive Vice President

Director
1,637
109.93
EUR 198,576
1,637 109.93 EUR 179,951
2023-09-06 2023-09-04 S Sale

YASHA MITROTTI VENTURA

Directeur Exécutif

Officer
1,790
96.03
EUR 185,254
1,790 96.03 EUR 171,897
2023-09-06 2023-09-04 S Sale

MARK MILLER

Directeur Exécutif Affaires Médicales

Officer
1,567
96.03
EUR 162,175
1,567 96.03 EUR 150,482
2023-07-25 2023-06-23 B Purchase

François LACOSTE

Executive Vice-President Research & Development

Director
26
77.31
EUR 2,191
26 77.31 EUR 2,000
2023-06-28 2023-06-23 B Purchase

MARK MILLER

Executive Vice Pdt, Chief Medical Officer

Officer
300
115.82
USD 34,746
300 115.82 USD 34,746
2023-06-28 2023-06-23 B Purchase

Pierre BOULUD

Directeur General Delegue

Officer
332
77.31
EUR 28,135
332 77.31 EUR 25,677
2023-06-27 2023-06-23 B Purchase

Guillaume BOUHOURS

Executive Vice Pdt, Chief Financial Officer

Officer
323
77.31
EUR 27,392
323 77.31 EUR 25,000
2023-06-27 2023-06-23 B Purchase

Valerie LEYLDE

Executive Vice Pdt, Human Resources, Communication & CSR

323
77.31
EUR 27,392
323 77.31 EUR 25,000
2023-06-27 2023-06-23 B Purchase

Yasha MITROTTI

Executive Vice Pdt, Industrial Microbiology

300
77.31
EUR 25,413
300 77.31 EUR 23,193
2023-03-24 2023-03-23 S Sale

Pierre Charbonnier

Directeur Exécutif Qualité Globale, Manufacturing & Supply Chain

Officer
16,500
100.03
EUR 1,791,691
16,500 100.03 EUR 1,650,416
2023-03-24 2023-03-23 S Sale

Pierre Charbonnire

EVP MSC&Q

Officer
16,500
100.20
EUR 1,794,822
16,500 100.20 EUR 1,653,300
2022-03-09 2022-02-26 S Sale

YASHA MITROTTI VENTURA

Executive Vice President Industrial Microbiology Business Unit

Director
2,350
86.82
EUR 179,507
2,350 86.82 EUR 204,032
2022-03-08 2022-02-26 S Sale

YASHA MITROTTI VENTURA

Executive Vice President Industrial Microbiology Business Unit

Director
2,350
86.82
EUR 179,507
2,350 86.82 EUR 204,032
2022-03-08 2022-02-26 S Sale

MARK MILLER

Chief Medical Officer

Officer
2,830
86.82
EUR 216,172
2,830 86.82 EUR 245,706
2021-05-24 2021-05-21 S Sale

Marie-Hélène HABERT

Administrateur

Through GROUPE INDUSTRIEL MARCEL DASSAULT SAS, a closely affiliated person Director
17,000
4.45
EUR 66,557
17,000 4.45 EUR 75,650
2021-05-21 2021-05-20 S Sale

Marie-Hélène HABERT

Administrateur

Through GROUPE INDUSTRIEL MARCEL DASSAULT SAS, a closely affiliated person Director
17,000
4.78
EUR 71,433
17,000 4.78 EUR 81,192
2021-05-06 2021-05-04 S Sale

Marie-Hélène HABERT

Administrateur

Through GROUPE INDUSTRIEL MARCEL DASSAULT SAS, a closely affiliated person Director
17,000
3.26
EUR 48,708
17,000 3.26 EUR 55,362
// ... existing code ...